Results 11 to 20 of about 608,521 (211)

Hemolysis After Transcatheter Mitral Valve Implantation Resolved by Valve Retensioning. [PDF]

open access: yesJACC Case Rep, 2021
Transcatheter mitral valve implantation is an emerging technology for the treatment of inoperable or high-risk patients with symptomatic severe mitral regurgitation.
Reineke D   +8 more
europepmc   +4 more sources

Transfemoral Transcatheter Mitral Valve Implantation With a Dedicated Device in a Rheumatic Mitral Stenosis Patient [PDF]

open access: yesJACC: Case Reports, 2023
A 65-year-old obese woman with rheumatic heart disease and restrictive lung disease presented with decompensated heart failure. Evaluation demonstrated severely thickened mitral valve leaflets, severe mitral stenosis, and moderate mitral regurgitation ...
Lauren S. Ranard, MD   +4 more
doaj   +2 more sources

Effects of Transapical Transcatheter Mitral Valve Implantation [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2021
Purpose: In this study, transapical transcatheter mitral valve-in-valve implantation (TAMVI) was compared with surgical redo mitral valve replacement (SRMVR) in terms of clinical outcomes.Methods: We retrospectively identified patients with degenerated mitral bioprosthesis or failed annuloplasty rings who underwent redo SRMVR or TAMVI at our medical ...
Ming-Chon Hsiung   +15 more
openaire   +4 more sources

Contemporary treatment of mitral valve disease with transcatheter mitral valve implantation [PDF]

open access: yesClinical Research in Cardiology, 2022
Abstract Background Transcatheter mitral valve implantation (TMVI) with self-expanding (SAV) or balloon-expandable (BAV) valves are rising as promising treatment options for high-risk patients with symptomatic mitral valve (MVD) disease unsuitable for alternative treatment options. Aims
Hendrik Wienemann   +10 more
openaire   +3 more sources

Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient [PDF]

open access: yesJournal of Cardiothoracic Surgery, 2017
Background Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) is now the treatment of choice in high-surgical-risk patients with failing aortic bioprosthesis. Although less performed, VIV-Transcatheter Mitral Valve Replacement (TMVR) is a
Marco Zanobini   +7 more
doaj   +2 more sources

The results of transcatheter mitral valve replacement [PDF]

open access: yesРоссийский кардиологический журнал, 2018
Mitral insufficiency is one of the most common valvular pathology. In almost half of the patients, standard mitral valve replacement using extracorporeal circulation cannot be used due to the high risk of complications. In recent years, for this category
R. M. Sharifulin   +5 more
doaj   +2 more sources

Transcatheter Aortic Valve Implantation in Patients With Mitral Prosthesis

open access: yesJournal of the American College of Cardiology, 2012
To the Editor: Transcatheter aortic valve implantation (TAVI) is an important therapeutic strategy for high-risk patients with severe aortic stenosis. Recently, this technique has proven to be as effective as surgery in reducing mortality at 2 years in this population ([1][1]).
Barbanti M   +17 more
openaire   +5 more sources

First experience of transcatheter implantation of a Russian-made MedLab-CT prosthesis in a patient with dysfunction of biological mitral valve prosthesis [PDF]

open access: yesРоссийский кардиологический журнал, 2020
We present a case report of successful transcatheter implantation of a Russian-made cardiac valve prosthesis in a patient with dysfunction of biological mitral valve prosthesis (valve-in-valve).
A. V. Bogachev-Prokofiev   +11 more
doaj   +2 more sources

Challenges and Open Issues in Transcatheter Mitral Valve Implantation: Smooth Seas Do Not Make Skillful Sailors [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2022
According to the European and American guidelines, surgery represents the treatment of choice for mitral valve (MV) disease. However, a number of patients are deemed unsuitable for surgery due to a prohibitive/high operative risk.
Giulio Russo   +12 more
doaj   +2 more sources

Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses [PDF]

open access: yesFrontiers in Cardiovascular Medicine
In patients undergoing transcatheter aortic valve implantation (TAVI), multi-valve disease is common and associated with worse outcomes. Despite multiple emerging transcatheter valve treatment options, no guidelines exist for the transcatheter treatment ...
Benjamin Mothibe Bussmann   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy